These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8239591)

  • 1. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin.
    Akova M; Uzun O; Akalin HE; Hayran M; Unal S; Gür D
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1831-4. PubMed ID: 8239591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.
    Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H
    Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179].
    Karabay O; Sencan I; Kayas D; Sahin I
    BMC Infect Dis; 2004 Jun; 4():18. PubMed ID: 15214959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.
    Solera J; Rodríguez-Zapata M; Geijo P; Largo J; Paulino J; Sáez L; Martínez-Alfaro E; Sánchez L; Sepulveda MA; Ruiz-Ribó MD
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2061-7. PubMed ID: 8540716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three different combination therapies in the treatment of human brucellosis.
    Ersoy Y; Sonmez E; Tevfik MR; But AD
    Trop Doct; 2005 Oct; 35(4):210-2. PubMed ID: 16354469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis.
    Ariza J; Gudiol F; Pallarés R; Rufí G; Fernández-Viladrich P
    Antimicrob Agents Chemother; 1985 Oct; 28(4):548-51. PubMed ID: 4073878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis.
    Saltoglu N; Tasova Y; Inal AS; Seki T; Aksu HS
    Saudi Med J; 2002 Aug; 23(8):921-4. PubMed ID: 12235463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis.
    Mile B; Valerija K; Krsto G; Ivan V; Ilir D; Nikola L
    Trop Doct; 2012 Jan; 42(1):13-7. PubMed ID: 22290107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis.
    Keramat F; Ranjbar M; Mamani M; Hashemi SH; Zeraati F
    Trop Doct; 2009 Oct; 39(4):207-10. PubMed ID: 19762571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study.
    Ariza J; Gudiol F; Pallares R; Viladrich PF; Rufi G; Corredoira J; Miravitlles MR
    Ann Intern Med; 1992 Jul; 117(1):25-30. PubMed ID: 1596044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin.
    Shasha B; Lang R; Rubinstein E
    Antimicrob Agents Chemother; 1992 May; 36(5):973-6. PubMed ID: 1510422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis.
    Ranjbar M; Keramat F; Mamani M; Kia AR; Khalilian FO; Hashemi SH; Nojomi M
    Int J Infect Dis; 2007 Mar; 11(2):152-6. PubMed ID: 16798042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load.
    Vrioni G; Bourdakis A; Pappas G; Pitiriga V; Mavrouli M; Pournaras S; Tsakris A
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7541-4. PubMed ID: 25246401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed cryoglobulinemia with renal failure, cutaneous vasculitis and peritonitis due to Brucella melitensis.
    Hermida Lazcano I; Sáez Méndez L; Solera Santos J
    J Infect; 2005 Dec; 51(5):e257-9. PubMed ID: 15951018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative therapeutic and multicenter trial of rifampicin and doxycycline versus streptomycin and doxycycline in human brucellosis].
    Solera J; Medrano F; Rodríguez M; Geijo P; Paulino J
    Med Clin (Barc); 1991 May; 96(17):649-53. PubMed ID: 1905372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis.
    Colmenero Castillo JD; Hernandez Marquez S; Reguera Iglesias JM; Cabrera Franquelo F; Rius Diaz F; Alonso A
    Chemotherapy; 1989; 35(2):146-52. PubMed ID: 2667903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of prolonged treatment with ciprofloxacin in acute infections due to Brucella melitensis.
    Lang R; Raz R; Sacks T; Shapiro M
    J Antimicrob Chemother; 1990 Dec; 26(6):841-6. PubMed ID: 2081722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Short communication: Investigation of in vitro antibiotic susceptibility of Brucella melitensis].
    Alişkan H; Turunç T; Demiroğlu YZ; Colakoğlu S; Arslan H
    Mikrobiyol Bul; 2008 Jan; 42(1):125-9. PubMed ID: 18444570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brucella canis endocarditis: case report.
    Ying W; Nguyen MQ; Jahre JA
    Clin Infect Dis; 1999 Dec; 29(6):1593-4. PubMed ID: 10585833
    [No Abstract]   [Full Text] [Related]  

  • 20. Early clinical response to different therapeutic regimens for human brucellosis.
    Malik GM
    Am J Trop Med Hyg; 1998 Feb; 58(2):190-1. PubMed ID: 9502602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.